Skip to content

Clinical trials

Bronchial Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Diseases Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20121
20133
20145
20152
20164
20172
20182
20191
20201
20222
20233
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting3
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca15
Novartis Pharmaceuticals3
Columbia University2
Upstream Bio Inc.2
Aevice Health Pte. Ltd.1
Albert Einstein College of Medicine1
Blueprint Medicines Corporation1
Brigham and Women's Hospital1
DARTNet Institute1
David Van Sickle1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Diseases34
Lung Diseases30
Respiratory Tract Diseases29
Asthma27
Lung Diseases, Obstructive25
Immune System Diseases9
Respiratory Hypersensitivity8
Hypersensitivity6
Hypersensitivity, Immediate5
Pulmonary Disease, Chronic Obstructive3

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.